Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Research Review

Showing 1–3 of 3 articles · Keyword: Nanocarrier Clear keyword

Nanomedicine (London, England)2026ResearchDrug Delivery

1. When structural sophistication becomes a translational barrier: the complexity trap in DNA nanocarrier design

Tunc Cu, Saha Sk, Panda Ss, Mori S, Culha M

DNA nanotechnology has emerged as a highly programmable platform in nanomedicine, enabling the fabrication of precise nanoscale architectures for drug delivery, biosensing, gene regulation, immunotherapy, and theranostics. DNA-based nanocarriers offer distinctive advantages, including structural programmability…

Read the article

Discover nano2026ReviewNon-viral Gene DeliveryDrug Delivery

2. Exosomes in regenerative medicine from biological messengers to engineered nanocarriers for precision therapeutics

Ghosh S, Bhaskar R, Singh Kk, Sharma S, Han Ss, Sinha Jk

Exosomes have emerged as a promising class of next-generation nanocarriers at the intersection of regenerative medicine and drug delivery. Compared with conventional synthetic nanocarriers and stem cell-based therapies, exosomes offer unique advantages, including intrinsic biocompatibility, low immunogenicity…

Read the article

Acta pharmaceutica (Zagreb, Croatia)2026ResearchNon-viral Gene DeliveryDrug Delivery

3. Nanocarrier based drug delivery for rheumatoid arthritis: Current strategies and future directions

Li N, Qu Z, Du D

The application of nanotechnology in drug delivery systems has attracted considerable scientific interest, particularly with respect to improving the therapeutic efficacy and safety profiles of pharmacological agents. This review critically examines nanotechnology-based drug delivery systems for the management of…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.